Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853163 · ClinicalTrials.gov registry record · NA
Long-Term Retention of Gadolinium in Bone
A NA study of Focus: Long-term Retention of Gadolinium-based Contrast Agent, sponsored by Navitas Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 16
- Study locations
NCT01853163 is a NA study of Focus: Long-term Retention of Gadolinium-based Contrast Agent that has completed, run by Navitas Life Sciences. The registered enrollment target is 92 participants. The trial reports 16 study locations across 2 states.
The verdict
NCT01853163, a NA study of Focus: Long-term Retention of Gadolinium-based Contrast Agent, has completed, sponsored by Navitas Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 16
- Study locations
Study Summary
The main objective was to prospectively explore the potential for long-term retention of Gadolinium (Gd) in bones in patients who have received a single dose of Gadolinium-based contrast agents (GBCA) or multiple doses of the same GBCA, with moderate or severe renal impairment or stable normal renal function (eGFR \> 60 ml/min/1.73 m2) at the time of GBCA injection.
Conditions Studied
Interventions
- PROCEDURE Gadolinium analysis in bone and tissue samples
Study Locations (16)
Other
- University Hospital Halle (Saale) - Halle
- University Hospital Magdeburg - Magdeburg
- University Hospital Würzburg - Würzburg
- Fukuoka Orthopaedic Hospital - Fukuoka
- Nissan Tamagawa Hospital - Tokyo
- Asan Medical Center Orthopedic Surgery - Seoul
- SMG-SNU Boramae Medical Center - Seoul
- Hospital Universitario Fundación Alcorcón - Alcorcón
- Hospital Vall d'Hebron - Barcelona
- H.G.U. Gregorio Marañón - Madrid
- Koc University Hospital, Orthopaedics and Traumatology Department - Istanbul
- Acibadem Hospital, Department of Orthopaedics and Traumatology - Istanbul
- Fatih Sultan Mehmet Training and Research Hospital, Department of Orthopedics and Traumatology - Istanbul
- Istanbul Sisli Hamidiye Etfal Egitim ve Arastirma Hastanesi - Istanbul
- Dokuz Eylul University Tıp Faculty - Izmir
California
- Cedar-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2013-05-06 |
| Est. Completion | 2018-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853163
The ClinicalTrials.gov registry entry for NCT01853163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Navitas Life Sciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Focus: Long-term Retention of Gadolinium-based Contrast Agent appearing as the primary indexed condition, and to 1 intervention - of which Gadolinium analysis in bone and tissue samples is the first listed.
NCT01853163 reports 16 study locations spanning 2 distinct geographic areas - top geographies include Other, California.
Frequently Asked Questions
What is clinical trial NCT01853163 about?
NCT01853163 is a clinical study titled "Long-Term Retention of Gadolinium in Bone". The main objective was to prospectively explore the potential for long-term retention of Gadolinium (Gd) in bones in patients who have received a single dose of Gadolinium-based contrast agents (GBCA) or multiple doses of the same GBCA, with moderate or severe renal impairment or stable normal renal...
What is the current status of trial NCT01853163?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2013-05-06. Estimated completion is 2018-12-17.
What conditions does trial NCT01853163 study?
This clinical trial studies the following conditions: Focus: Long-term Retention of Gadolinium-based Contrast Agent.
What interventions are being tested in trial NCT01853163?
The interventions under investigation include: Gadolinium analysis in bone and tissue samples (PROCEDURE).
Who is sponsoring clinical trial NCT01853163?
This trial is sponsored by Navitas Life Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01853163 being conducted?
This trial has 16 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.